Synthesis of Tricyclic Compounds as Steroid 5[alpha]-Reductase Inhibitors

A series of 4-phenoxybutyric acid derivatives attached to a tricyclic skelton were prepared and evaluated as 5α-reductase inhibitors. Structure activity relationships for these compounds in terms of rat epididymls (type 2)5α-reductase inhibitory activities reveal that 1) the substitution pattern at...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 48; no. 4; p. 552
Main Authors TAKAMI, Hitoshi, NONAKA, Hiromi, KISHIBAYASHI, Nobuyuki, ISHII, Akio, KASE, Hiroshi, KUMAZAWA, Toshiaki
Format Journal Article
LanguageEnglish
Published Tokyo Japan Science and Technology Agency 01.04.2000
Online AccessGet full text

Cover

More Information
Summary:A series of 4-phenoxybutyric acid derivatives attached to a tricyclic skelton were prepared and evaluated as 5α-reductase inhibitors. Structure activity relationships for these compounds in terms of rat epididymls (type 2)5α-reductase inhibitory activities reveal that 1) the substitution pattern at the 11-position of dibenz[b, e]oxepin influenced potency, 2) higher lipophilicity of the tricylic skeleton improved potency, whereas the existence of a basic nitrogen atom in this skeleton was detrimental to potency, and 3) isobutyl substitution at the 8 position of the azepine skelton was tolerated. Among the tricyclic compounds studied, 4-[3-[5-benzyl-8-(2-methyl)propyl-10, 11-dihydrodibenz[b, f]azepine-2-carboxamido]phenoxy]butyric adid (26) was the most potent inhibitor of rat type 2 5α-reductase at 0.1μM.
ISSN:0009-2363
1347-5223